Literature DB >> 14686785

Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells.

Naomi Matoh1, Seigo Tanaka, Masanori Takehashi, Marek Banasik, Todd Stedeford, Eliezer Masliah, Shigehiko Suzuki, Yoshihiko Nishimura, Kunihiro Ueda.   

Abstract

Clonal pheochromocytoma cell lines overexpressing cytochrome P450 2D6 (CYP2D6) were established. CYP2D6 was localized in the endoplasmic reticulum, and its enzymatic activity in the microsomal fraction was confirmed by using high performance liquid chromatography analysis with [guanidine-14C]debrisoquine as a substrate. Overexpression of CYP2D6 protected both actively dividing and differentiated cells against the toxic effects of 1-methyl-4-phenylpyridinium ion at the concentration range of 20-40 microM, as assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The production of reactive oxygen species in the mitochondria was suppressed. The cytotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine was unchanged in both actively dividing and differentiated cells overexpressing CYP2D6 versus mock-transfected controls at concentrations up to 500 microM. These results suggest that the lowered enzyme activity of CYP2D6 in individuals termed "poor metabolizers" may represent a risk factor from exposure to select neurotoxicants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14686785      PMCID: PMC5991163          DOI: 10.3727/000000003108749017

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  32 in total

1.  Organochlorine insecticides in substantia nigra in Parkinson's disease.

Authors:  F M Corrigan; C L Wienburg; R F Shore; S E Daniel; D Mann
Journal:  J Toxicol Environ Health A       Date:  2000-02-25

2.  Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions.

Authors:  T S Smith; J P Bennett
Journal:  Brain Res       Date:  1997-08-15       Impact factor: 3.252

3.  Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.

Authors:  J P Hubble; J H Kurth; S L Glatt; M C Kurth; G D Schellenberg; R E Hassanein; A Lieberman; W C Koller
Journal:  Neuroepidemiology       Date:  1998       Impact factor: 3.282

4.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.

Authors:  T Coleman; S W Ellis; I J Martin; M S Lennard; G T Tucker
Journal:  J Pharmacol Exp Ther       Date:  1996-05       Impact factor: 4.030

Review 5.  Oxygen activation by cytochrome P-450.

Authors:  R E White; M J Coon
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

Review 6.  Isoquinoline neurotoxins in the brain and Parkinson's disease.

Authors:  T Nagatsu
Journal:  Neurosci Res       Date:  1997-10       Impact factor: 3.304

7.  Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

Authors:  K Chiba; E Kubota; T Miyakawa; Y Kato; T Ishizaki
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

8.  Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes.

Authors:  S Puntarulo; A I Cederbaum
Journal:  Free Radic Biol Med       Date:  1998-05       Impact factor: 7.376

9.  Redox cycling of MPP+: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase.

Authors:  L K Klaidman; J D Adams; A C Leung; S S Kim; E Cadenas
Journal:  Free Radic Biol Med       Date:  1993-08       Impact factor: 7.376

10.  Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.

Authors:  J R Cashman; D M Ziegler
Journal:  Mol Pharmacol       Date:  1986-02       Impact factor: 4.436

View more
  9 in total

1.  Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells.

Authors:  Amandeep Mann; Rachel F Tyndale
Journal:  Eur J Neurosci       Date:  2010-03-22       Impact factor: 3.386

2.  The neurotoxicology of hard foraging and fat-melts.

Authors:  Caleb E Finch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

Review 3.  Cytochrome P450-mediated drug metabolism in the brain.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

Review 4.  Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.

Authors:  Chaitali Ghosh; Vikram Puvenna; Jorge Gonzalez-Martinez; Damir Janigro; Nicola Marchi
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

5.  Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.

Authors:  R T Miller; S Miksys; E Hoffmann; R F Tyndale
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Drosophila CYP6g1 and its human homolog CYP3A4 confer tolerance to methylmercury during development.

Authors:  Matthew D Rand; Jessica A Lowe; Cecon T Mahapatra
Journal:  Toxicology       Date:  2012-06-12       Impact factor: 4.221

7.  Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.

Authors:  Amandeep Mann; Sharon Miksys; Anna Lee; Deborah C Mash; Rachel F Tyndale
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

8.  Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Marlaina R Stocco; Cole Tolledo; Fariba Baghai Wadji; Frank J Gonzalez; Sharon Miksys; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-08-06       Impact factor: 5.590

9.  β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration.

Authors:  Jesus Fernandez-Abascal; Elda Chiaino; Maria Frosini; Gavin P Davey; Massimo Valoti
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.